Abstract: The present invention relates to vulcanizable polymer compositions comprising a very low molecular weight optionally hydrogenated nitrile rubber, at least one cross-linking agent, optionally at least one filler and optionally one or more further auxiliary products for rubbers, a process for preparing such vulcanizable polymer compositions, furtheron a process for vulcanizing such polymer compositions and the resulting vulcanizate, preferably as a shaped article.

Abstract: A novel process for the metathetic degradation of nitrile rubbers is provided which uses specific transition metal complex catalysts showing an increased activity.

Abstract: Pursuant to the invention a process for the production of hydrogenated nitrile rubber polymers having lower molecular weights and narrower molecular weight distributions than those known in the art in the is provided wherein the process is carried out in the presence of hydrogen and optionally at least one co-(olefin). The present invention further relates to the use of specific metal compounds in a process for the production of a hydrogenated nitrile rubber by simultaneous hydrogenation and metathesis of a nitrile rubber.

Abstract: The present invention relates to a low molecular weight optionally hydrogenated nitrile rubber and a process for preparing a low molecular weight optionally hydrogenated nitrile rubber by molecular weight degradation of nitrile rubbers via a metathesis process in the presence of a transition metal complex catalyst in a specific reaction mixture, a polymer composite comprising at least one optionally hydrogenated nitrile rubber, at least one cross-linking agent and/or curing system, optionally at least one filler and optionally further auxiliary products for rubbers and a shaped article comprising the optionally hydrogenated nitrile rubber or the composite.

Abstract: The present invention relates to a process for the metathesis of nitrile rubbers in the presence of a specific catalyst for the metathetic degradation of nitrile rubber. The present invention further relates to specific novel metathesis catalysts and to the use thereof for the metathesis of nitrile rubbers.

Abstract: The present invention relates to a process for the production of hydrogenated nitrile rubber polymers having lower molecular weights and narrower molecular weight distributions than those known in the art, wherein the process is carried out in the presence of hydrogen and optionally at least one co-olefin. The present invention further relates to the use of specific metal compounds in a process for the production of a hydrogenated nitrile rubber by simultaneous hydrogenation and metathesis of a nitrile rubber.

Abstract: The present invention includes the use of pelorol, related compounds and pharmaceutical compositions thereof as modulators of SHIP 1 activity. This invention also provides novel terpene compounds capable of modulating SHIP 1 activity and methods of synthesis thereof.

Abstract: A process of degrading nitrile rubbers comprises subjecting them to a metathesis reaction in the presence of specific catalysts with increased activity.

Abstract: This invention provides a method for identifying allosteric modulators of a SHIP polypeptide, wherein said SHIP polypeptide is contacted with a test compound, and wherein said SHIP polypeptide comprises an allosteric site selected from the group consisting of a SHIP C2 domain and a SHIP PH domain.

Abstract: Novel optionally hydrogenated nitrile rubbers distinguised by a very low ruthenium content are provided as well as a process for the removal of ruthenium-containing catalyst residues from a solution of optionally hydrogenated nitrile rubber by using specific functionalized ion-exchange resins.

Abstract: A novel vulcanizable polymer composition is provided which is characterized by a specific combination of a polyamine crosslinking agent, a particular crosslinking accelerator and an alkali metal salt. Further on polymer vulcanizates on the basis of such polymer compositions as well as a method for preparing such polymer vulcanizates is provided, in particular in the form of mouldings or shaped parts.

Abstract: The invention provides, in part, compositions and methods for protecting a hemopoietic cell, or for treating myelosuppression, in a subject in need thereof, by administering an effective amount of an inhibitor of a SH2-containing inositol-5?-phosphatase.

Abstract: A novel vulcanizable polymer composition is provided which is characterized by a specific combination of a polyamine crosslinking agent and a particular crosslinking accelerator. Furtheron polymer vulcanizates on the basis of such polymer compositions as well as method for preparing such polymer vulcanizate is provided, in particular in the form of mouldings or shaped parts.

Abstract: Novel crosslinkable compositions based on elastomers, at least one of which has carboxyl and/or carboxylate groups, are provided, these crosslinkable compositions containing special unsaturated organic salts of metal ions and a crosslinking system which acts as a free radical donor. Crosslinked elastomers which have excellent physical properties are obtainable therefrom. The novel crosslinkable compositions have a wide range of uses.

Abstract: Novel crosslinkable compositions based on elastomers, at least one of which has carboxyl and/or carboxylate groups, are provided, these crosslinkable compositions containing special unsaturated organic salts of metal ions and a crosslinking system which acts as a free radical donor. Crosslinked elastomers which have excellent physical properties are obtainable therefrom. The novel crosslinkable compositions have a wide range of uses.

Abstract: A cancer is evaluated for selection of appropriate therapy by evaluating a sample of cancerous tissue to determine an expression of level of phosphatase and tensin homologue deleted from chromosome 10 (PTEN); and in the case where the expression level of functional PTEN is below a threshold level, identifying the cancer as susceptible to an active agent that inhibits the expression of heat shock protein 27 (hsp27). The evaluation may be included as part of a method of treatment, in which an hsp27 inhibitor is selected as a therapeutic agent when the PTEN level is below the threshold.

Abstract: A process is provided for the removal of iron-residues, rhodium- and/or ruthenium-containing catalyst residues from a solution of optionally hydrogenated nitrile rubber containing such iron-residues, rhodium- and/or ruthenium-containing residues by contacting such solution with a specific functionalized ion exchange resin.

Abstract: Novel optionally hydrogenated nitrite rubbers distinguised by a very low ruthenium content are provided as well as a process for the removal of ruthenium-containing catalyst residues from a solution of optionally hydrogenated nitrite rubber by using specific functionalized ion-exchange resins.

Abstract: A novel process for the metathetic degradation of nitrile rubbers is provided which uses specific transition metal complex catalysts showing an increased activity.

Abstract: The present invention includes the use of pelorol, related compounds and pharmaceutical compositions thereof as modulators of SHIP 1 activity. This invention also provides novel terpene compounds capable of modulating SHIP 1 activity and methods of synthesis thereof.